163 related articles for article (PubMed ID: 10471443)
21. Protection against ischemic hippocampal CA1 damage in the rat with a new non-NMDA antagonist, NBQX.
Diemer NH; Jørgensen MB; Johansen FF; Sheardown M; Honoré T
Acta Neurol Scand; 1992 Jul; 86(1):45-9. PubMed ID: 1325729
[TBL] [Abstract][Full Text] [Related]
22. In vivo and in vitro evaluation of AMPA receptor antagonists in rat hippocampal neurones and cultured mouse cortical neurones.
Mathiesen C; Varming T; Jensen LH
Eur J Pharmacol; 1998 Jul; 353(2-3):159-67. PubMed ID: 9726646
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture.
Hewett SJ; Uliasz TF; Vidwans AS; Hewett JA
J Pharmacol Exp Ther; 2000 May; 293(2):417-25. PubMed ID: 10773011
[TBL] [Abstract][Full Text] [Related]
24. Long-term elevation of cyclooxygenase-2, but not lipoxygenase, in regions synaptically distant from spreading depression.
Caggiano AO; Breder CD; Kraig RP
J Comp Neurol; 1996 Dec; 376(3):447-62. PubMed ID: 8956110
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death.
Strauss KI; Marini AM
J Neurotrauma; 2002 May; 19(5):627-38. PubMed ID: 12042097
[TBL] [Abstract][Full Text] [Related]
26. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
Ruiz A; Durand J
Brain Res Bull; 2000 May; 52(2):99-107. PubMed ID: 10808079
[TBL] [Abstract][Full Text] [Related]
27. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.
Beubler E; Schuligoi R; Chopra AK; Ribardo DA; Peskar BA
J Pharmacol Exp Ther; 2001 Jun; 297(3):940-5. PubMed ID: 11356914
[TBL] [Abstract][Full Text] [Related]
28. The AMPA antagonist, NBQX, protects against ischemia-induced loss of cerebellar Purkinje cells.
Balchen T; Diemer NH
Neuroreport; 1992 Sep; 3(9):785-8. PubMed ID: 1384770
[TBL] [Abstract][Full Text] [Related]
29. Low endogenous glucocorticoid allows induction of kidney cortical cyclooxygenase-2 during postnatal rat development.
Madsen K; Stubbe J; Yang T; Skøtt O; Bachmann S; Jensen BL
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F26-37. PubMed ID: 13129852
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
[TBL] [Abstract][Full Text] [Related]
31. (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18986-1) a positive modulator of AMPA receptors enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices.
Lockhart B; Iop F; Closier M; Lestage P
Eur J Pharmacol; 2000 Aug; 401(2):145-53. PubMed ID: 10924919
[TBL] [Abstract][Full Text] [Related]
32. The effect of an AMPA antagonist (NBQX) on postischemic neuron loss and protein synthesis in the rat brain.
Frank L; Bruhn T; Diemer NH
Exp Brain Res; 1993; 95(1):70-6. PubMed ID: 7691645
[TBL] [Abstract][Full Text] [Related]
33. Over-additive protective effect of dizocilpine and NBQX against neuronal damage.
Lippert K; Welsch M; Krieglstein J
Eur J Pharmacol; 1994 Mar; 253(3):207-13. PubMed ID: 7911083
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 mRNA expression is associated with c-fos mRNA expression and transient water ADC reduction detected with diffusion MRI during acute focal ischemia in rats.
Mancuso A; Derugin N; Hara K; Marsh TA; Kong D; Sharp FR; Weinstein PR
Brain Res; 2003 Jan; 961(1):121-30. PubMed ID: 12535784
[TBL] [Abstract][Full Text] [Related]
35. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
von Euler M; Seiger A; Holmberg L; Sundström E
Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838
[TBL] [Abstract][Full Text] [Related]
36. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury.
Abraham KE; McGinty JF; Brewer KL
Neuroscience; 2001; 104(3):863-74. PubMed ID: 11440816
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of NBQX on hypoxia-induced neuronal damage in rat hippocampus.
Matsuoka Y; Kitamura Y; Tsukahara T; Terai K; Tooyama I; Kimura H; Taniguchi T
Neuroreport; 1995 Nov; 6(16):2205-8. PubMed ID: 8595203
[TBL] [Abstract][Full Text] [Related]
39. Nuclear factor kappaB activation is mediated by NMDA and non-NMDA receptor and L-type voltage-gated Ca(2+) channel following severe global ischemia in rat hippocampus.
Shen W; Zhang C; Zhang G
Brain Res; 2002 Apr; 933(1):23-30. PubMed ID: 11929632
[TBL] [Abstract][Full Text] [Related]
40. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
